)
)
)
MEDIC Life Sciences
MEDiC Life Sciences leverages millions of artificial biomarker combinations to advance novel cancer precision medicines with matched synthetic lethal biomarkers. We are currently building a growing pipeline of acquired or in-licensed clinical-stage assets and closed our first transactions in August 2025.
Address
Palo AltoCA
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)